Dr. David S. Goldstein, renowned as a founder and thought leader in autonomic medicine, has substantial experience and expertise in clinical catecholamine neurochemistry, sympathetic neuroimaging, autonomic pathophysiology, mechanisms of catecholaminergic neurodegeneration, and stress and homeostasis as medical scientific ideas. He received his BA from Yale College and M.D.-Ph.D. in Behavioral Sciences from Johns Hopkins. After internal medical residency at the University of Washington he came to the NIH as a Clinical Associate in the NHLBI in 1978, obtaining tenure as a Senior Investigator in 1984. He joined the NINDS in 1990 to head the Clinical Neurochemistry Section and founded the Clinical Neurocardiology Section (name changed to Autonomic Medicine Section in 2019). He has received Yale's Angier Prize for Research in Psychology, the Distinguished Investigator Award of the Society for Clinical and Translational Science, the NIH Distinguished Clinical Teacher Award, the Schatz Award of the American Academy of Neurology for research on autonomic disorders, and 2 NINDS Director's Awards for mentorship. He is a Fellow of the American Heart Association and the American Autonomic Society and a member of the Association of American Physicians.

Newly retired from the NIH, Dr. Goldstein founded and directs The Autonomic and Catecholamine Healthspan Institute, LLC (abbreviated ACHI).